RNA Equity Ratio

Atrium Therapeutics Inc · Equity Ratio

RNA logo

RNA Equity Ratio

Current (TTM)76.49%
RNA Equity Ratio (74.47% → 76.49%)
High-resolution chart · PNG

RNA equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
74.4691%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.